$3.40
arrow_drop_down3.95%Key Stats | |
---|---|
Open | $3.50 |
Prev. Close | $3.51 |
EPS | -1.27 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $208.57M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 3.46 | 3.65 |
52 Week Range | 1.35 | 6.85 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.27 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops Revenue Estimates
Does Pyxis Oncology (PYXS) Have the Potential to Rally 61.29% as Wall Street Analysts Expect?
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session